{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T22:23:37Z","timestamp":1770330217207,"version":"3.49.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education Malaysia","doi-asserted-by":"crossref","award":["FRGS\/1\/2023\/WAB13\/UPSI\/03\/1, Grant Code 2023-0090-108-02"],"award-info":[{"award-number":["FRGS\/1\/2023\/WAB13\/UPSI\/03\/1, Grant Code 2023-0090-108-02"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Chem Res"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00044-025-03519-w","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T22:02:18Z","timestamp":1767477738000},"page":"304-315","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Flavonoids as colchicine binding site inhibitors: emerging scaffolds in anticancer drug design"],"prefix":"10.1007","volume":"35","author":[{"given":"Ahmed","family":"Maebed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhanis","family":"Mhd Bakri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasser M.","family":"Omar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saripah Salbiah","family":"Syed Abdul Azziz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abu-Baker M.","family":"Abdel-Aal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,3]]},"reference":[{"key":"3519_CR1","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1002\/ijc.34002","volume":"151","author":"CJ Cabasag","year":"2022","unstructured":"Cabasag CJ, Fagan PJ, Ferlay J, Vignat J, Laversanne M, Liu L, et al. Ovarian cancer today and tomorrow: a global assessment by world region and human development index using GLOBOCAN 2020. Int J cancer. 2022;151:1535\u201341.","journal-title":"Int J cancer"},{"key":"3519_CR2","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.mehy.2014.01.004","volume":"82","author":"DJ Benjamin","year":"2014","unstructured":"Benjamin DJ. The efficacy of surgical treatment of cancer \u2013 20years later. Med Hypotheses. 2014;82:412\u201320.","journal-title":"Med Hypotheses"},{"key":"3519_CR3","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0140-6736(21)00233-6","volume":"398","author":"RA Chandra","year":"2021","unstructured":"Chandra RA, Keane FK, Voncken FEM, Thomas CR. Contemporary radiotherapy: present and future. Lancet. 2021;398:171\u201384.","journal-title":"Lancet"},{"key":"3519_CR4","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20230334","volume":"96","author":"T Mee","year":"2023","unstructured":"Mee T, Kirkby NF, Defourny NN, Kirkby KJ, Burnet NG. The use of radiotherapy, surgery and chemotherapy in the curative treatment of cancer: results from the FORTY (Favourable Outcomes from RadioTherapY) project. Br J Radiology. 2023;96:20230334.","journal-title":"Br J Radiology"},{"key":"3519_CR5","first-page":"209","volume":"25","author":"A Letai","year":"2025","unstructured":"Letai A, de The H. Conventional chemotherapy: millions of cures, unresolved therapeutic index. Nat Rev Cancer. 2025;25:209\u201318.","journal-title":"Nat Rev Cancer"},{"key":"3519_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.113581","volume":"200","author":"I Gomez-Randulfe","year":"2024","unstructured":"Gomez-Randulfe I, Leporati R, Gupta B, Liu S, Califano R. Recent advances and future strategies in first-line treatment of ES-SCLC. Eur J Cancer. 2024;200:113581.","journal-title":"Eur J Cancer"},{"key":"3519_CR7","doi-asserted-by":"publisher","first-page":"682","DOI":"10.4251\/wjgo.v8.i9.682","volume":"8","author":"F Aroldi","year":"2016","unstructured":"Aroldi F, Bertocchi P, Savelli G, Rosso E, Zaniboni A. Pancreatic cancer: new hopes after first line treatment. World J Gastrointest Oncol. 2016;8:682\u20137.","journal-title":"World J Gastrointest Oncol"},{"key":"3519_CR8","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1038\/s12276-022-00864-3","volume":"54","author":"HY Min","year":"2022","unstructured":"Min HY, Lee HY. Molecular targeted therapy for anticancer treatment. Exp Mol Med. 2022;54:1670\u201394.","journal-title":"Exp Mol Med"},{"key":"3519_CR9","doi-asserted-by":"publisher","first-page":"13007","DOI":"10.1039\/D0NJ01194K","volume":"44","author":"A El-Kardocy","year":"2020","unstructured":"El-Kardocy A, Mostafa YA, Mohamed NG, Abo-Zeid MN, Hassan NA, Hetta HF, et al. CK2 inhibition, lipophilicity and anticancer activity of new N1versus N2-substituted tetrabromobenzotriazole regioisomers. N J Chem. 2020;44:13007\u201317.","journal-title":"N J Chem"},{"key":"3519_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00706-020-02716-0","volume":"152","author":"M Mustafa","year":"2021","unstructured":"Mustafa M, El-Kardocy A, Mostafa YA. Development of new hetero-steroid hybrids with antiproliferative activity against MCF-7 breast cancer cells. Monatshefte f\u00fcr Chem - Chem Monthly. 2021;152:137\u201349.","journal-title":"Monatshefte f\u00fcr Chem - Chem Monthly"},{"key":"3519_CR11","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1007\/s00044-019-02438-x","volume":"28","author":"A El-Kardocy","year":"2019","unstructured":"El-Kardocy A, Mustafa M, Ahmed ER, Mohamady S, Mostafa YA. Aryl azide-sulfonamide hybrids induce cellular apoptosis: synthesis and preliminary screening of their cytotoxicity in human HCT116 and A549 cancer cell lines. Medicinal Chem Res. 2019;28:2088\u201398.","journal-title":"Medicinal Chem Res"},{"key":"3519_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1146\/annurev.cellbio.13.1.83","volume":"13","author":"A Desai","year":"1997","unstructured":"Desai A, Mitchison TJ. Microtubule polymerization dynamics. Annu Rev Cell Developmental Biol. 1997;13:83\u2013117.","journal-title":"Annu Rev Cell Developmental Biol"},{"key":"3519_CR13","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.3390\/cells8101294","volume":"8","author":"P Binarov\u00e1","year":"2019","unstructured":"Binarov\u00e1 P, Tuszynski J. Tubulin: structure, functions and roles in disease. Cells. 2019;8:1294.","journal-title":"Cells"},{"key":"3519_CR14","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41580-021-00399-x","volume":"22","author":"NB Gudimchuk","year":"2021","unstructured":"Gudimchuk NB, McIntosh JR. Regulation of microtubule dynamics, mechanics and function through the growing tip. Nat Rev Mol Cell Biol. 2021;22:777\u201395.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3519_CR15","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1002\/med.21568","volume":"39","author":"KE Arnst","year":"2019","unstructured":"Arnst KE, Banerjee S, Chen H, Deng S, Hwang D-J, Li W, et al. Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy. Medicinal Res Rev. 2019;39:1398\u2013426.","journal-title":"Medicinal Res Rev"},{"key":"3519_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S0955-0674(98)80082-3","volume":"10","author":"KH Downing","year":"1998","unstructured":"Downing KH, Nogales E. Tubulin and microtubule structure. Curr Opin Cell Biol. 1998;10:16\u201322.","journal-title":"Curr Opin Cell Biol"},{"key":"3519_CR17","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.21037\/tcr-20-682","volume":"9","author":"Z Cheng","year":"2020","unstructured":"Cheng Z, Lu X, Feng B. A review of research progress of antitumor drugs based on tubulin targets. Transl cancer Res. 2020;9:4020\u20137.","journal-title":"Transl cancer Res"},{"key":"3519_CR18","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.3390\/biom12121843","volume":"12","author":"M Hawash","year":"2022","unstructured":"Hawash M. Recent advances of tubulin inhibitors targeting the colchicine binding site for cancer therapy. Biomolecules. 2022;12:1843.","journal-title":"Biomolecules"},{"key":"3519_CR19","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1080\/13543776.2023.2291390","volume":"33","author":"MN Peerzada","year":"2023","unstructured":"Peerzada MN, Dar MS, Verma S. Development of tubulin polymerization inhibitors as anticancer agents. Expert Opin therapeutic Pat. 2023;33:797\u2013820.","journal-title":"Expert Opin therapeutic Pat"},{"key":"3519_CR20","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.3390\/cancers12071721","volume":"12","author":"D Zhang","year":"2020","unstructured":"Zhang D, Kanakkanthara A. Beyond the paclitaxel and vinca alkaloids: next generation of plant-derived microtubule-targeting agents with potential anticancer activity. Cancers. 2020;12:1721.","journal-title":"Cancers"},{"key":"3519_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev.cellbio.16.1.89","volume":"16","author":"KH Downing","year":"2000","unstructured":"Downing KH. Structural basis for the interaction of tubulin with proteins and drugs that affect microtubule dynamics. Annu Rev Cell developmental Biol. 2000;16:89\u2013111.","journal-title":"Annu Rev Cell developmental Biol"},{"key":"3519_CR22","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1080\/13543776.2016.1214268","volume":"26","author":"A Mandhare","year":"2016","unstructured":"Mandhare A, Banerjee P. Therapeutic use of colchicine and its derivatives: a patent review. Expert Opin Therapeutic Pat. 2016;26:1157\u201374.","journal-title":"Expert Opin Therapeutic Pat"},{"key":"3519_CR23","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/bjd.15896","volume":"178","author":"B Dasgeb","year":"2018","unstructured":"Dasgeb B, Kornreich D, McGuinn K, Okon L, Brownell I, Sackett DL. Colchicine: an ancient drug with novel applications. Br J dermatology. 2018;178:350\u20136.","journal-title":"Br J dermatology"},{"key":"3519_CR24","first-page":"281","volume":"16","author":"A G\u00fcl","year":"2014","unstructured":"G\u00fcl A. Treatment of familial Mediterranean fever: colchicine and beyond. Isr Med Assoc J. 2014;16:281\u20134.","journal-title":"Isr Med Assoc J"},{"key":"3519_CR25","doi-asserted-by":"publisher","unstructured":"Ben-Chetrit E. Colchicine. In: Hashkes P, Laxer R, Simon A. (eds). Textbook of autoinflammation. Springer, Cham; 2019. https:\/\/doi.org\/10.1007\/978-3-319-98605-0_40.","DOI":"10.1007\/978-3-319-98605-0_40"},{"key":"3519_CR26","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1097\/MCG.0b013e31803815b4","volume":"42","author":"A Kamath","year":"2008","unstructured":"Kamath A, Mehal W, Jain D. Colchicine-associated ring mitosis in liver biopsy and their clinical implications. J Clin gastroenterology. 2008;42:1060\u20132.","journal-title":"J Clin gastroenterology"},{"key":"3519_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-019-0365-z","volume":"20","author":"D Wang","year":"2019","unstructured":"Wang D, Xie Y, Yan M, Pan Q, Liang Y, Sun X. Colchicine causes prenatal cell toxicity and increases tetraploid risk. BMC pharmacology Toxicol. 2019;20:66.","journal-title":"BMC pharmacology Toxicol"},{"key":"3519_CR28","first-page":"e53","volume":"8","author":"M Rahimi","year":"2020","unstructured":"Rahimi M, Alizadeh R, Hassanian-Moghaddam H, Zamani N, Kargar A, Shadnia S. Clinical manifestations and outcomes of colchicine poisoning cases; a cross sectional study. Arch academic Emerg Med. 2020;8:e53.","journal-title":"Arch academic Emerg Med"},{"key":"3519_CR29","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.3390\/molecules30102186","volume":"30","author":"CN Reed","year":"2025","unstructured":"Reed CN, Garrison KB, Thammathong J, Cinatl J, Michaelis M, Banerjee S, et al. Colchicine binding site tubulin inhibitors impair vincristine-resistant neuroblastoma cell function. Molecules. 2025;30:2186.","journal-title":"Molecules"},{"key":"3519_CR30","doi-asserted-by":"publisher","first-page":"29448","DOI":"10.1021\/acsomega.3c02979","volume":"8","author":"A Sargsyan","year":"2023","unstructured":"Sargsyan A, Sahakyan H, Nazaryan K. Effect of colchicine binding site inhibitors on the tubulin intersubunit interaction. ACS Omega. 2023;8:29448\u201354.","journal-title":"ACS Omega"},{"key":"3519_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.117021","volume":"281","author":"M Fantacuzzi","year":"2025","unstructured":"Fantacuzzi M, Carradori S, Giampietro L, Maccallini C, De Filippis B, Amoroso R, et al. A novel life for antitumor combretastatins: recent developments of hybrids, prodrugs, combination therapies, and antibody-drug conjugates. Eur J medicinal Chem. 2025;281:117021.","journal-title":"Eur J medicinal Chem"},{"key":"3519_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2174\/1389557522666220602103104","volume":"23","author":"C Prerna","year":"2023","unstructured":"Prerna C, Vivek A, Shivangi A, Varsha K, Ratnesh D, Sushil Kumar K. Structural perspective of benzophenones targeting tubulin as anticancer agents. Mini-Reviews Medicinal Chem. 2023;23:33\u201352.","journal-title":"Mini-Reviews Medicinal Chem"},{"key":"3519_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2023.101016","volume":"6","author":"FE Ali","year":"2023","unstructured":"Ali FE, Salem OIA, El-Mokhtar MA, Aboraia AS, Abdel-Moty SG, Abdel-Aal A-BM. Design, synthesis and antiproliferative evaluation of lipidated 1,3-diaryl propenones and their cyclized pyrimidine derivatives as tubulin polymerization inhibitors. Results Chem. 2023;6:101016.","journal-title":"Results Chem"},{"key":"3519_CR34","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1021\/acs.jnatprod.2c00793","volume":"86","author":"SM Mohamed","year":"2023","unstructured":"Mohamed SM, Abou-Ghadir OMF, El-Mokhtar MA, Aboraia AS. Abdel\u2212Aal A-BM. Fatty Acid Conjugated Chalcones as Tubulin Polymerization Inhibitors: Design, Synthesis, QSAR, and Apoptotic and Antiproliferative Activity. J Nat Products. 2023;86:1150\u20138.","journal-title":"J Nat Products"},{"key":"3519_CR35","doi-asserted-by":"publisher","first-page":"7835","DOI":"10.1080\/07391102.2022.2126397","volume":"41","author":"A Biharee","year":"2023","unstructured":"Biharee A, Yadav A, Jangid K, Singh Y, Kulkarni S, Sawant DM, et al. Flavonoids as promising anticancer agents: an in silico investigation of ADMET, binding affinity by molecular docking and molecular dynamics simulations. J Biomolecular Structure Dyn. 2023;41:7835\u201346.","journal-title":"J Biomolecular Structure Dyn"},{"key":"3519_CR36","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12575-010-9029-5","volume":"12","author":"S Fortin","year":"2010","unstructured":"Fortin S, Lacroix J, C\u00f4t\u00e9 MF, Moreau E, Petitclerc E. R CG. Quick and simple detection technique to assess the binding of antimicrotubule agents to the colchicine-binding site. Biol Proced online. 2010;12:113\u20137.","journal-title":"Biol Proced online"},{"key":"3519_CR37","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.drudis.2021.12.001","volume":"27","author":"J Wang","year":"2022","unstructured":"Wang J, Miller DD, Li W. Molecular interactions at the colchicine binding site in tubulin: an X-ray crystallography perspective. Drug discovery today. 2022;27:759\u201376.","journal-title":"Drug discovery today"},{"key":"3519_CR38","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/cbdd.12132","volume":"82","author":"JY Mane","year":"2013","unstructured":"Mane JY, Semenchenko V, Perez-Pineiro R, Winter P, Wishart D, Tuszynski JA. Experimental and computational study of the interaction of novel colchicinoids with a recombinant human \u03b1I\/\u03b2I-tubulin heterodimer. Chem Biol drug Des. 2013;82:60\u201370.","journal-title":"Chem Biol drug Des"},{"key":"3519_CR39","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jchromb.2019.05.010","volume":"1121","author":"M Xu","year":"2019","unstructured":"Xu M, Xu Y, Shen Y, Lou C, Zheng M, Kang J. Determining the affinity of anti-mitotic compounds binding to colchicine binding site of tubulin by affinity probe capillary electrophoresis. J Chromatogr B. 2019;1121:66\u201371.","journal-title":"J Chromatogr B"},{"key":"3519_CR40","doi-asserted-by":"publisher","DOI":"10.1017\/jns.2016.41","volume":"5","author":"AN Panche","year":"2016","unstructured":"Panche AN, Diwan AD, Chandra SR. Flavonoids: an overview. J nutritional Sci. 2016;5:e47.","journal-title":"J nutritional Sci"},{"key":"3519_CR41","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3390\/molecules28010426","volume":"28","author":"AM Pereira","year":"2023","unstructured":"Pereira AM, Cidade H, Tiritan ME. Stereoselective synthesis of flavonoids: a brief overview. Molecules. 2023;28:426.","journal-title":"Molecules"},{"key":"3519_CR42","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.2174\/0115680266316032240718050055","volume":"24","author":"B Singh","year":"2024","unstructured":"Singh B, Semwal BC. A compressive review on source, toxicity and biological activity of flavonoid. Curr Top medicinal Chem. 2024;24:2093\u2013116.","journal-title":"Curr Top medicinal Chem"},{"key":"3519_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e27533","volume":"10","author":"H Hasnat","year":"2024","unstructured":"Hasnat H, Shompa SA, Islam MM, Alam S, Richi FT, Emon NU, et al. Flavonoids: a treasure house of prospective pharmacological potentials. Heliyon. 2024;10:e27533.","journal-title":"Heliyon"},{"key":"3519_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2025.152245","volume":"777","author":"Y Su","year":"2025","unstructured":"Su Y, Yan W, Yang J, Yang F. Structure of quercetin 3,4\u2019-dimethyl ether in complex with tubulin provides a rationale for drug design. Biochemical biophysical Res Commun. 2025;777:152245.","journal-title":"Biochemical biophysical Res Commun"},{"key":"3519_CR45","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1080\/01635580802521346","volume":"61","author":"YS Touil","year":"2009","unstructured":"Touil YS, Arlette F, Daniel S, Chabot GG. Flavonoid-induced morphological modifications of endothelial cells through microtubule stabilization. Nutr Cancer. 2009;61:310\u201321.","journal-title":"Nutr Cancer"},{"key":"3519_CR46","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0960-894X(01)81233-6","volume":"3","author":"JA Beutler","year":"1993","unstructured":"Beutler JA, Cardellina JH, Lin CM, Hamel E, Cragg GM, Boyd MR. Centaureidin, a cytotoxic flavone from polymnia fruticosa, inhibits tubulin polymerization. Bioorganic Medicinal Chem Lett. 1993;3:581\u20134.","journal-title":"Bioorganic Medicinal Chem Lett"},{"key":"3519_CR47","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3390\/nu12020457","volume":"12","author":"DM Kopustinskiene","year":"2020","unstructured":"Kopustinskiene DM, Jakstas V, Savickas A, Bernatoniene J. Flavonoids as Anticancer Agents. Nutrients. 2020;12:457.","journal-title":"Nutrients"},{"key":"3519_CR48","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/med.10033","volume":"23","author":"W Ren","year":"2003","unstructured":"Ren W, Qiao Z, Wang H, Zhu L, Zhang L. Flavonoids: promising anticancer agents. Medicinal Res Rev. 2003;23:519\u201334.","journal-title":"Medicinal Res Rev"},{"key":"3519_CR49","doi-asserted-by":"publisher","first-page":"691","DOI":"10.2174\/1568011023353714","volume":"2","author":"M Lopez-Lazaro","year":"2002","unstructured":"Lopez-Lazaro M. Flavonoids as anticancer agents: structure-activity relationship study. Curr Medicinal Chem - Anti-Cancer Agents. 2002;2:691\u2013714.","journal-title":"Curr Medicinal Chem - Anti-Cancer Agents"},{"key":"3519_CR50","doi-asserted-by":"publisher","first-page":"663","DOI":"10.2174\/138955707781024463","volume":"7","author":"Y Li","year":"2007","unstructured":"Li Y, Fang H, Xu W. Recent advance in the research of flavonoids as anticancer agents. Mini Rev Medicinal Chem. 2007;7:663\u201378.","journal-title":"Mini Rev Medicinal Chem"},{"key":"3519_CR51","first-page":"737","volume":"25","author":"B Kapoor","year":"2021","unstructured":"Kapoor B, Gulati M, Gupta R, Singh SK, Gupta M, Nabi A, et al. A review on plant flavonoids as potential anticancer agents. Curr Org Chem. 2021;25:737\u201347.","journal-title":"Curr Org Chem"},{"key":"3519_CR52","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1042\/BST20140073","volume":"42","author":"C Martinez-Perez","year":"2014","unstructured":"Martinez-Perez C, Ward C, Cook G, Mullen P, McPhail D, Harrison DJ, et al. Novel flavonoids as anti-cancer agents: mechanisms of action and promise for their potential application in breast cancer. Biochemical Soc Trans. 2014;42:1017\u201323.","journal-title":"Biochemical Soc Trans"},{"key":"3519_CR53","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.2174\/138527211796367363","volume":"15","author":"E Genoux","year":"2011","unstructured":"Genoux E, Nicolle E, Boumendjel A. Flavonoids as anticancer agents: recent progress and state of the art? Curr Org Chem. 2011;15:2608\u201315.","journal-title":"Curr Org Chem"},{"key":"3519_CR54","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s13205-013-0117-5","volume":"3","author":"P Batra","year":"2013","unstructured":"Batra P, Sharma AK. Anti-cancer potential of flavonoids: recent trends and future perspectives. 3 Biotech. 2013;3:439\u201359.","journal-title":"3 Biotech"},{"key":"3519_CR55","first-page":"1","volume":"5","author":"MK Chahar","year":"2011","unstructured":"Chahar MK, Sharma N, Dobhal MP, Joshi YC. Flavonoids: a versatile source of anticancer drugs. Pharmacognosy Rev. 2011;5:1\u201312.","journal-title":"Pharmacognosy Rev"},{"key":"3519_CR56","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1021\/np50118a001","volume":"58","author":"Q Shi","year":"1995","unstructured":"Shi Q, Chen K, Li L, Chang J-J, Autry C, Kozuka M, et al. Antitumor Agents, 154. cytotoxic and antimitotic flavonols from polanisia dodecandra. J Nat Products. 1995;58:475\u201382.","journal-title":"J Nat Products"},{"key":"3519_CR57","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1021\/jm970842h","volume":"41","author":"JA Beutler","year":"1998","unstructured":"Beutler JA, Hamel E, Vlietinck AJ, Haemers A, Rajan P, Roitman JN, et al. Structure\u2212activity requirements for flavone cytotoxicity and binding to tubulin. J Medicinal Chem. 1998;41:2333\u20138.","journal-title":"J Medicinal Chem"},{"key":"3519_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cbi.2015.06.034","volume":"239","author":"S Sinha","year":"2015","unstructured":"Sinha S, Amin H, Nayak D, Bhatnagar M, Kacker P, Chakraborty S, et al. Assessment of microtubule depolymerization property of flavonoids isolated from Tanacetum gracile in breast cancer cells by biochemical and molecular docking approach. Chemico-Biological Interact. 2015;239:1\u201311.","journal-title":"Chemico-Biological Interact"},{"key":"3519_CR59","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ejmech.2015.01.012","volume":"93","author":"LH Mai","year":"2015","unstructured":"Mai LH, Chabot GG, Grellier P, Quentin L, Dumontet V, Poulain C, et al. Antivascular and anti-parasite activities of natural and hemisynthetic flavonoids from new caledonian Gardenia species (Rubiaceae). Eur J Medicinal Chem. 2015;93:93\u2013100.","journal-title":"Eur J Medicinal Chem"},{"key":"3519_CR60","doi-asserted-by":"publisher","first-page":"13029","DOI":"10.1021\/bi025952r","volume":"41","author":"K Gupta","year":"2002","unstructured":"Gupta K, Panda D. Perturbation of microtubule polymerization by quercetin through tubulin binding:\u2009a novel mechanism of its antiproliferative activity. Biochemistry. 2002;41:13029\u201338.","journal-title":"Biochemistry"},{"key":"3519_CR61","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.biochi.2013.02.010","volume":"95","author":"D Choudhury","year":"2013","unstructured":"Choudhury D, Ganguli A, Dastidar DG, Acharya BR, Das A, Chakrabarti G. Apigenin shows synergistic anticancer activity with curcumin by binding at different sites of tubulin. Biochimie. 2013;95:1297\u2013309.","journal-title":"Biochimie"},{"key":"3519_CR62","doi-asserted-by":"publisher","first-page":"S564","DOI":"10.4103\/0973-1296.172962","volume":"11","author":"A Mira","year":"2015","unstructured":"Mira A, Shimizu K. In vitro cytotoxic activities and molecular mechanisms of angelica shikokiana extract and its isolated compounds. Pharmacognosy Mag. 2015;11:S564\u20139.","journal-title":"Pharmacognosy Mag"},{"key":"3519_CR63","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/mc.22055","volume":"53","author":"F Nicolini","year":"2014","unstructured":"Nicolini F, Burmistrova O, Marrero MT, Torres F, Hern\u00e1ndez C, Quintana J, et al. Induction of G2\/M phase arrest and apoptosis by the flavonoid tamarixetin on human leukemia cells. Mol carcinogenesis. 2014;53:939\u201350.","journal-title":"Mol carcinogenesis"},{"key":"3519_CR64","first-page":"3917","volume":"15","author":"J Wei","year":"2018","unstructured":"Wei J, Su H, Bi Y, Li J, Feng L, Sheng W. Anti-proliferative effect of isorhamnetin on HeLa cells through inducing G2\/M cell cycle arrest. Exp therapeutic Med. 2018;15:3917\u201323.","journal-title":"Exp therapeutic Med"},{"key":"3519_CR65","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1016\/j.bmcl.2009.05.008","volume":"19","author":"J Quintin","year":"2009","unstructured":"Quintin J, Buisson D, Thoret S, Cresteil T, Lewin G. Semisynthesis and antiproliferative evaluation of a series of 3\u2032-aminoflavones. Bioorganic Medicinal Chem Lett. 2009;19:3502\u20136.","journal-title":"Bioorganic Medicinal Chem Lett"},{"key":"3519_CR66","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1021\/np100065v","volume":"73","author":"G Lewin","year":"2010","unstructured":"Lewin G, Maciuk A, Thoret S, Aubert G, Dubois J, Cresteil T. Semisynthesis of natural flavones inhibiting tubulin polymerization, from hesperidin. J Nat Products. 2010;73:702\u20136.","journal-title":"J Nat Products"},{"key":"3519_CR67","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1021\/jm950923i","volume":"39","author":"Y Karton","year":"1996","unstructured":"Karton Y, Jiang JL, Ji XD, Melman N, Olah ME, Stiles GL, et al. Synthesis and biological activities of flavonoid derivatives as A3 adenosine receptor antagonists. J medicinal Chem. 1996;39:2293\u2013301.","journal-title":"J medicinal Chem"},{"key":"3519_CR68","doi-asserted-by":"publisher","first-page":"4671","DOI":"10.1111\/bph.13227","volume":"172","author":"C-Y Chiang","year":"2015","unstructured":"Chiang C-Y, Wang T-C, Lee C-H, Chen C-S, Wang S-H, Lin Y-C, et al. WTC-01, a novel synthetic oxime-flavone compound, destabilizes microtubules in human nasopharyngeal carcinoma cells in vitro and in vivo. Br J Pharmacology. 2015;172:4671\u201383.","journal-title":"Br J Pharmacology"},{"key":"3519_CR69","doi-asserted-by":"publisher","first-page":"6060","DOI":"10.1016\/j.bmc.2017.09.043","volume":"25","author":"F Est\u00e9vez-Sarmiento","year":"2017","unstructured":"Est\u00e9vez-Sarmiento F, Said M, Brouard I, Le\u00f3n F, Garc\u00eda C, Quintana J, et al. 3\u2032-Hydroxy-3,4\u2032-dimethoxyflavone blocks tubulin polymerization and is a potent apoptotic inducer in human SK-MEL-1 melanoma cells. Bioorganic Medicinal Chem. 2017;25:6060\u201370.","journal-title":"Bioorganic Medicinal Chem"},{"key":"3519_CR70","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1039\/C8NJ04533J","volume":"43","author":"X Deng","year":"2019","unstructured":"Deng X, Liu R, Li J, Li Z, Liu J, Xiong R, et al. Design, synthesis, and preliminary biological evaluation of 3\u2032,4\u2032,5\u2032-trimethoxy flavonoid salicylate derivatives as potential anti-tumor agents. N J Chem. 2019;43:1874\u201384.","journal-title":"N J Chem"},{"key":"3519_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.103652","volume":"96","author":"R Liu","year":"2020","unstructured":"Liu R, Deng X, Peng Y, Feng W, Xiong R, Zou Y, et al. Synthesis and biological evaluation of novel 5,6,7-trimethoxy flavonoid salicylate derivatives as potential anti-tumor agents. Bioorganic Chem. 2020;96:103652.","journal-title":"Bioorganic Chem"},{"key":"3519_CR72","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/cmdc.201100361","volume":"7","author":"A Massarotti","year":"2012","unstructured":"Massarotti A, Coluccia A, Silvestri R, Sorba G, Brancale A. The tubulin colchicine domain: a molecular modeling perspective. ChemMedChem. 2012;7:33\u201342.","journal-title":"ChemMedChem"},{"key":"3519_CR73","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1016\/S0031-9422(00)81695-7","volume":"25","author":"O Barber\u00e1","year":"1986","unstructured":"Barber\u00e1 O, Marco JA, Sanz JF, S\u00e1nchez-Parareda J. 3-Methoxyflavones and coumarins from artemisia incanescens. Phytochemistry. 1986;25:2357\u201360.","journal-title":"Phytochemistry"},{"key":"3519_CR74","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1021\/np50109a024","volume":"57","author":"JJ Lichius","year":"1994","unstructured":"Lichius JJ, Thoison O, Montagnac A, Pa\u00efs M, Gu\u00e9ritte-Voegelein F, S\u00e9venet T, et al. Antimitotic and cytotoxic flavonols from zieridium pseudobtusifolium and acronychia porteri. J Nat Products. 1994;57:1012\u20136.","journal-title":"J Nat Products"},{"key":"3519_CR75","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/S0031-9422(00)94716-2","volume":"10","author":"S Morris Kupchan","year":"1971","unstructured":"Morris Kupchan S, Bauerschmidt E. Cytotoxic flavonols from baccharis sarothroides. Phytochemistry. 1971;10:664\u20136.","journal-title":"Phytochemistry"},{"key":"3519_CR76","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1055\/s-2006-960826","volume":"65","author":"CW Huck","year":"1999","unstructured":"Huck CW, Huber Cg Fau -, Lagoja IM, Lagoja Im Fau -, Ongania KH, Ongania Kh Fau -, et al. Isolation and structural elucidation of 3\u2019,4\u2019,5\u2019-trimethoxyflavone from the flowers of Primula veris. Planta Med. 1999;65:491.","journal-title":"Planta Med"},{"key":"3519_CR77","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1021\/jm00106a047","volume":"34","author":"M Cushman","year":"1991","unstructured":"Cushman M, Nagarathnam D, Burg DL, Geahlen RL. Synthesis and protein-tyrosine kinase inhibitory activities of flavonoid analogs. J Medicinal Chem. 1991;34:798\u2013806.","journal-title":"J Medicinal Chem"},{"key":"3519_CR78","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1248\/cpb.41.714","volume":"41","author":"S Sugiyama","year":"1993","unstructured":"Sugiyama S, Umehara K, Kuroyanagi M, Ueno A, Taki T. Studies on the Differentiation Inducers of Myeloid Leukemic Cells from Citrus Species. CHEM PHARM Bull. 1993;41:714\u20139.","journal-title":"CHEM PHARM Bull"},{"key":"3519_CR79","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1248\/cpb.34.3727","volume":"34","author":"N Tanaka","year":"1986","unstructured":"Tanaka N, Wada H, Murakami T, Sahashi N, Ohmoto T. Chemische und Chemotaxonomische Untersuchungen der Pterophyten. LXIV. : chemische untersuchungen der Inhaltsstoffe von sceptridium ternatum var. ternatum. CHEM PHARM Bull. 1986;34:3727\u201332.","journal-title":"CHEM PHARM Bull"},{"key":"3519_CR80","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1016\/S0031-9422(00)91115-4","volume":"14","author":"AE Star","year":"1975","unstructured":"Star AE, R\u00f6sler H, Mabry TJ, Smith DM. Flavonoid and ceroptin pigments from frond exudates of pityrogramma triangularis. Phytochemistry. 1975;14:2275\u20138.","journal-title":"Phytochemistry"},{"key":"3519_CR81","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1016\/S0031-9422(00)80696-2","volume":"24","author":"N Fang","year":"1985","unstructured":"Fang N, Leidig M, Mabry TJ. Highly oxygenated flavonoid aglycones from gutierrezia grandis. Phytochemistry. 1985;24:2693\u20138.","journal-title":"Phytochemistry"},{"key":"3519_CR82","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1016\/S0031-9422(00)89891-X","volume":"10","author":"R Braz Filho","year":"1971","unstructured":"Braz Filho R, Gottlieb OR. The flavones of apuleia leiocarpa. Phytochemistry. 1971;10:2433\u201350.","journal-title":"Phytochemistry"},{"key":"3519_CR83","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/0040-4020(61)80014-8","volume":"15","author":"GP Sastry","year":"1961","unstructured":"Sastry GP, Row LR. Chemical investigation of citrus mitis Blanco\u2014III: Isolation of two new flavanones. Tetrahedron. 1961;15:111\u20134.","journal-title":"Tetrahedron"},{"key":"3519_CR84","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1021\/jf60141a013","volume":"13","author":"LJ Swift","year":"1965","unstructured":"Swift LJ. Orange peel constituents, flavones of neutral fraction of benzene extractables of orange peel juice. J Agric Food Chem. 1965;13:431\u20133.","journal-title":"J Agric Food Chem"},{"key":"3519_CR85","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/S0031-9422(00)89581-3","volume":"37","author":"A Skibinski","year":"1994","unstructured":"Skibinski A, Merfort I, Willuhn. Gn. Thirty-seven flavonoids from flowers ofArnica longifolia. Phytochemistry. 1994;37:1635\u20136.","journal-title":"Phytochemistry"},{"key":"3519_CR86","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1021\/np50001a002","volume":"42","author":"JM Edwards","year":"1979","unstructured":"Edwards JM, Raffauf RF, Le Quesne PW. Antineoplastic activity and cytotoxicity of flavones, isoflavones, and flavanones. J Nat Products. 1979;42:85\u201391.","journal-title":"J Nat Products"},{"key":"3519_CR87","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/BF00598368","volume":"22","author":"Chemesova II","year":"1986","unstructured":"Chemesova II, Markova LP. Flavonoid composition ofArtemisia halodendron. Chem Nat Compd. 1986;22:725.","journal-title":"Chem Nat Compd"},{"key":"3519_CR88","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1021\/jo01257a059","volume":"34","author":"SM Kupchan","year":"1969","unstructured":"Kupchan SM, Sigel CW, Knox JR, Udayamurthy MS. Tumor inhibitors. XXXVI. Eupatin and eupatoretin, two cytotoxic flavonols from Eupatorium semiserratum. J Org Chem. 1969;34:1460\u20133.","journal-title":"J Org Chem"},{"key":"3519_CR89","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0040-4020(01)93331-9","volume":"8","author":"PS Sarin","year":"1960","unstructured":"Sarin PS, Seshadri TR. New components of Citrus aurantium. Tetrahedron. 1960;8:64\u20136.","journal-title":"Tetrahedron"},{"key":"3519_CR90","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0031-9422(00)97104-8","volume":"36","author":"VS Parmar","year":"1994","unstructured":"Parmar VS, Bisht KS, Sharma SK, Jain R, Taneja P, Singh S, et al. Highly oxygenated bioactive flavones from tamarix. Phytochemistry. 1994;36:507\u201311.","journal-title":"Phytochemistry"},{"key":"3519_CR91","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1016\/0031-9422(72)80123-7","volume":"11","author":"SS Subramanian","year":"1972","unstructured":"Subramanian SS, Nair AGR. Scutellarein and pectolinaringenin from the leaves of clerodendron phlomides and duranta repens. Phytochemistry. 1972;11:3095\u20136.","journal-title":"Phytochemistry"},{"key":"3519_CR92","first-page":"22","volume":"2","author":"P Lakhanpal","year":"2007","unstructured":"Lakhanpal P, Rai DK. Quercetin: a versatile flavonoid. Internet J Med Update. 2007;2:22\u201337.","journal-title":"Internet J Med Update"},{"key":"3519_CR93","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1002\/mnfr.201600025","volume":"60","author":"RK Lall","year":"2016","unstructured":"Lall RK, Adhami VM, Mukhtar H. Dietary flavonoid fisetin for cancer prevention and treatment. Mol Nutr Food Res. 2016;60:1396\u2013405.","journal-title":"Mol Nutr Food Res"},{"key":"3519_CR94","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1007\/s11095-010-0089-7","volume":"27","author":"S Shukla","year":"2010","unstructured":"Shukla S, Gupta S. Apigenin: a promising molecule for cancer prevention. Pharm Res. 2010;27:962\u201378.","journal-title":"Pharm Res"},{"key":"3519_CR95","doi-asserted-by":"publisher","first-page":"298","DOI":"10.2174\/138955711795305335","volume":"11","author":"J M. Calderon-Montano","year":"2011","unstructured":"M. Calderon-Montano J, Burgos-Moron E, Perez-Guerrero C, Lopez-Lazaro M. A review on the dietary flavonoid kaempferol. Mini-Reviews Medicinal Chem. 2011;11:298\u2013344.","journal-title":"Mini-Reviews Medicinal Chem"},{"key":"3519_CR96","doi-asserted-by":"publisher","first-page":"774","DOI":"10.2174\/0929867323666160106150821","volume":"23","author":"A Caselli","year":"2016","unstructured":"Caselli A, Cirri P, Santi A, Paoli P. Morin: a promising natural drug. Curr Medicinal Chem. 2016;23:774\u201391.","journal-title":"Curr Medicinal Chem"},{"key":"3519_CR97","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3390\/molecules24030390","volume":"24","author":"X Ren","year":"2019","unstructured":"Ren X, Bao Y, Zhu Y, Liu S, Peng Z, Zhang Y, et al. Isorhamnetin, hispidulin, and cirsimaritin identified in tamarix ramosissima barks from southern xinjiang and their antioxidant and antimicrobial activities. Molecules. 2019;24:390.","journal-title":"Molecules"}],"container-title":["Medicinal Chemistry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-025-03519-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00044-025-03519-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-025-03519-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:03:35Z","timestamp":1770285815000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00044-025-03519-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,3]]},"references-count":97,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["3519"],"URL":"https:\/\/doi.org\/10.1007\/s00044-025-03519-w","relation":{},"ISSN":["1054-2523","1554-8120"],"issn-type":[{"value":"1054-2523","type":"print"},{"value":"1554-8120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,3]]},"assertion":[{"value":"7 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}